We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Four Point Test Flags Patients at Risk of Dying from Clostridium difficile Infection

By LabMedica International staff writers
Posted on 20 Aug 2013
Analysis of metabolic and mortality data from a group of patients with Clostridium difficile infections has allowed the establishment of a prediction rule based on clinical variables to aid hospital physicians to rank incoming patients according to risk of dying from the infection.

C. More...
difficile is an anaerobic, spore forming, rod shaped bacterium, and is a prevalent cause of nosocomial infection. Furthermore, antibiotic resistant strains of C. difficile are a growing problem in healthcare systems. Recent C. difficile epidemics have been caused by hypervirulent strains, which became resistant to the fluoroquinolones soon after their introduction into the healthcare setting.

When C. difficile bacteria are introduced into a colon in which the normal gut flora has been destroyed (usually after a broad-spectrum antibiotic such as clindamycin has been used), the gut becomes overrun with C. difficile. This overpopulation is harmful because the bacteria release toxins that can cause bloating and diarrhea, with abdominal pain, which may become severe. C. difficile infections are the most common cause of pseudomembranous colitis, and in rare cases, this can progress to toxic megacolon, which can be life threatening.

Investigators at the University of Exeter (United Kingdom) and the Royal Devon & Exeter Hospital (United Kingdom) evaluated over 186 variables collated retrospectively from clinical data for 213 patients. From this data, they devised a simple four variable prediction rule that included serum albumin levels, respiratory rate, C-reactive protein, and white cell count. Threshold levels of these variables were associated with an increased risk of all-cause mortality.

Contributing author Dr. Steve Michell, senior lecturer in molecular microbiology at the University of Exeter, said, "Our findings are exciting because they identify a simple, accurate, and robust method to identify those patients who are at risk of dying from a C difficile infection. The clinical variables identified are easily measurable, using tests that are commonly carried out in hospital. The results of our study strengthen the evidence for establishing the use of this rule in clinical settings: the benefits to patient well-being, the efficient management of infection in hospital and potential savings to the NHS and other health services around the world, would be immense."

The study was published in the July 12, 2013, online edition of the journal BMC Infectious Diseases.

Related Links:
University of Exeter
Royal Devon & Exeter Hospital


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Hematology Consumables
Bioblood Devices
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The findings support integrating high-performing plasma p-tau217 assays into Alzheimer’s diagnostic workflows, provided that platform-specific calibration and standardized testing protocols are in place. (Image Credit: Adobe Stock)

Head-to-Head Study Compares Blood Tests for Early Alzheimer’s Disease Detection

Accurate, scalable diagnostics are becoming increasingly important as disease-modifying therapies reshape Alzheimer’s disease care, yet many patients still rely on invasive cerebrospinal fluid sampling... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.